Linkcelltx
Founded 2022 · 2 known investors
Link Cell Therapies develops CAR T cell therapies using logic-gate ("AND-gate") technology that requires co-expression of cancer targets to increase specificity for tumors. The company targets solid tumors and certain hematologic cancers.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Linkcelltx was founded in 2022 by Robbie Majzner and Crystal Mackall.
RM
Robbie Majzner
CM
Crystal Mackall
JC
Jerry CaciaChief Operating Officer
MW
Mark WalletChief Scientific Officer
Investors · 2
Competitors · 2
by search overlapLyell33 shared keywordsLyell is a clinical-stage biotech developing next-generation CAR T-cell product candidates intended as one-time treatments for patients with cancer, targeting both hematologic malignancies and solid tumors. The company owns and operates its own manufacturing facility to control its cell therapy supply chain.
Kite Pharma32 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.
Companies competing with Linkcelltx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Linkcelltx do?
- Link Cell Therapies develops CAR T cell therapies using logic-gate ("AND-gate") technology that requires co-expression of cancer targets to increase specificity for tumors. The company targets solid tumors and certain hematologic cancers.
- Who founded Linkcelltx?
- Linkcelltx was founded by Robbie Majzner, Crystal Mackall in 2022.
- Who are Linkcelltx's investors?
- Linkcelltx's investors include Samsara BioCapital, Wing.